Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.
about
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategiesSystems biology of cisplatin resistance: past, present and futureTargeting the Bcl-2 family for cancer therapyImmunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapyAdvances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin AnalogsDesigning biomarker studies for head and neck cancer.HPV-associated head and neck cancer: a virus-related cancer epidemic.Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinomaDKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell linesDownregulation of Vascular Endothelial Growth Factor Enhances Chemosensitivity by Induction of Apoptosis in Hepatocellular Carcinoma Cells.Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cellsHigh XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma.Quantification of endothelial cell-targeted anti-Bcl-2 therapy and its suppression of tumor growth and vascularization.Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA libraryHER2 expression predicts improved survival in patients with cervical node-positive head and neck squamous cell carcinoma.CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin.ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer.Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis.Classifying squamous cell carcinoma of the head and neck: prognosis, prediction and implications for therapy.MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer.miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1.SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma.RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance.Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma.Heat shock response associated with hepatocarcinogenesis in a murine model of hereditary tyrosinemia type I.BH3 mimetic Obatoclax (GX15-070) mediates mitochondrial stress predominantly via MCL-1 inhibition and induces autophagy-dependent necroptosis in human oral cancer cells.CpG oligodeoxynucleotides enhance chemosensitivity of 5-fluorouracil in HepG2 human hepatoma cells via downregulation of the antiapoptotic factors survivin and livin.P2Y11 impairs cell proliferation by induction of cell cycle arrest and sensitizes endothelial cells to cisplatin-induced cell death.Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.Asplatin enhances drug efficacy by altering the cellular response.Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines.Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.53BP1 inhibits the migration and regulates the chemotherapy resistance of ovarian cancer cells.
P2860
Q26750639-04194B9A-AF9F-4D5F-9D8D-DCB009481739Q26863585-C1EAC1A9-8126-4CBD-8EB5-12DB49E25666Q26866936-02B3EE59-061A-4C21-A2C8-642B7E723374Q27027093-B836D763-F546-45B0-9A26-5A87CD859491Q33610394-55C6B20C-B9A5-45ED-B7CA-D41A2EBB766BQ33683394-4474F7E9-5A2F-4C5D-8B65-46B2836557BFQ33971467-DD797EAD-F141-4D99-A016-70D69549ABB4Q34114152-BCF5793E-00D0-4EA7-9DC3-B1F3054B2CEBQ34231282-FBEC1195-1A81-436B-9558-BC7A36DCCAE9Q35106254-BB0B55EA-57B2-4F3E-B06B-EE729C9A590BQ35768464-50D346B3-9374-4C6E-B68A-B86C8282E09BQ35856029-AC2FDC79-0925-4CCF-B528-7F121D97F811Q36567569-7B27AFBD-8560-4587-ABD8-585C7D1D9AFEQ37046690-AF90DA7B-384A-414F-8A13-1A42D1D36974Q37050088-FBBFB200-B236-49E7-8729-C2E7802FC11FQ37419813-33ACABF2-4439-4552-8077-7619FB9A9468Q37446629-D205FF67-AB59-4D19-955D-1FF8161D38AEQ37604597-D014B906-FB6B-43F8-8F54-DFD962379DBCQ37611042-EE990826-C5B1-4CAE-A76D-3E0C01047B3BQ37693895-63822754-24C9-4283-B5DB-7F34F2CF4F37Q37712188-76A64A9B-8382-4D4C-840A-6D2F43656E4EQ38045266-17E8B164-468F-48D7-B657-B6AA76E69E3DQ38169227-25FA42AE-E5CB-45A8-B9C9-CC1663B4FED2Q38938572-77491CBE-ABF3-472C-8C5C-C5F8AF457AEEQ39119238-CA1D8FE4-B392-45E8-903F-BAABC3177413Q39153932-EE46500B-A695-4EDB-8BE0-65667EC2FB1DQ39218915-D3A08412-B9F8-4D46-87DD-03308B47B769Q39268126-A632C2A3-1CB6-47AB-B569-B619C3F2BFA4Q39551449-477693BE-0A92-44E6-9E4C-3E9786CA546AQ41457848-5ED74BC8-E5A1-412B-B582-EF63567376CEQ41694352-789C6CDD-5AF1-4070-A1FE-023C47A606E7Q41885916-ED9A097C-A4FF-469A-AC57-B6885C0F77FBQ42742419-B21F0E01-8814-4A2E-B8F7-149002AC812FQ45808925-98E1AAB3-F0EC-4F69-8F65-A3BAD49C93C4Q48786961-4D0B1719-246C-41B6-A035-9C8B80C8C727Q49805034-3E22576E-C190-4338-B73C-AC76560306DAQ50494309-53B175C5-4A86-465A-A5C2-BEAA127DE18DQ55280419-4CDF9C6F-6229-4E87-A257-67FA0A4DB8F0
P2860
Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bcl-2 blocks cisplatin-induced ...... ngeal squamous cell carcinoma.
@en
Bcl-2 blocks cisplatin-induced ...... ngeal squamous cell carcinoma.
@nl
type
label
Bcl-2 blocks cisplatin-induced ...... ngeal squamous cell carcinoma.
@en
Bcl-2 blocks cisplatin-induced ...... ngeal squamous cell carcinoma.
@nl
prefLabel
Bcl-2 blocks cisplatin-induced ...... ngeal squamous cell carcinoma.
@en
Bcl-2 blocks cisplatin-induced ...... ngeal squamous cell carcinoma.
@nl
P2093
P2860
P1476
Bcl-2 blocks cisplatin-induced ...... ngeal squamous cell carcinoma.
@en
P2093
Edmund A Mroz
Hiroshi Wada
James W Rocco
John R Clark
Leif W Ellisen
Paul M Busse
Shahnaz Begum
William A Michaud
William C Faquin
William H Westra
P2860
P304
P356
10.1158/1078-0432.CCR-08-2581
P407
P577
2009-02-24T00:00:00Z